Beta Bionics Raises FY2026 Sales Guidance from $121.000M-$126.000M to $124.000M-$126.000M vs $126.626M Est
Benzinga Newsdesk 5 days ago
NewsGuidance
Beta Bionics (NASDAQ:BBNX) raises FY2026 sales outlook from $121.000 million-$126.000 million to $124.000 million-$126.000 million vs $126.626 million estimate.
Beta Bionics (NASDAQ:BBNX) raises FY2026 sales outlook from $121.000 million-$126.000 million to $124.000 million-$126.000 million vs $126.626 million estimate.